Home › Compare › NXRT vs AMGN

NXRT vs AMGN: Dividend Comparison 2026

NXRT yields 4.00% · AMGN yields 4.00%● Live data

vsPost on X →
10 years
NXRT
NXRT
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NXRT calculator →
AMGN
AMGN
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full AMGN calculator →

Portfolio growth — NXRT vs AMGN

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXRTAMGN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXRT + AMGN cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NXRT pays
AMGN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXRT
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
AMGN
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXRT + AMGN for your $10,000?

NXRT: 50%AMGN: 50%
100% AMGN50/50100% NXRT
Portfolio after 10yr
$28.0K
Annual income
$899.20/yr
Blended yield
3.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AMGN right now

NXRT
Analyst Ratings
3
Buy
6
Hold
1
Sell
Consensus: Hold
Price Target
$27.00
-46.0% upside vs current
Range: $27.00 — $27.00
Altman Z
0.8
Piotroski
6/9
AMGN
Analyst Ratings
22
Buy
13
Hold
3
Sell
Consensus: Buy
Price Target
$347.73
+595.5% upside vs current
Range: $185.00 — $432.00
Altman Z
2.3
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXRT buys
0
AMGN buys
0
No recent congressional trades found for NXRT or AMGN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXRTAMGN
Forward yield4.00%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth5%5%
5-year div CAGR5%5%
Portfolio after 10y$28.0K$28.0K
Annual income after 10y$899.19$899.19
Total dividends collected$6.4K$6.4K
Payment frequencyquarterlyquarterly
SectorREITHealthcare
Analyst consensusHoldBuy
Analyst price target$27.00$347.73 ✓

Year-by-year: NXRT vs AMGN ($10,000, DRIP)

YearNXRT PortfolioNXRT Income/yrAMGN PortfolioAMGN Income/yrGap
1$11,120$420.00$11,120$420.00$0.00 → AMGN
2$12,357$458.31$12,357$458.31$0.00 → AMGN
3$13,721$499.76$13,721$499.76$0.00 → AMGN
4$15,227$544.58$15,227$544.58$0.00 → AMGN
5$16,885$593.02$16,885$593.02$0.00 → AMGN
6$18,713$645.34$18,713$645.34$0.00 → AMGN
7$20,724$701.81$20,724$701.81$0.00 → AMGN
8$22,938$762.73$22,938$762.73$0.00 → AMGN
9$25,372$828.41$25,372$828.41$0.00 → AMGN
10$28,047$899.19$28,047$899.19$0.00 → AMGN

NXRT vs AMGN: Complete Analysis 2026

NXRT — REIT

NXRT is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NXRT shares.

Full NXRT Calculator →

AMGN — Healthcare

AMGN is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in AMGN shares.

Full AMGN Calculator →
📬

Get this NXRT vs AMGN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXRT vs SCHDNXRT vs JEPINXRT vs ONXRT vs KONXRT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.